Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

370 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO).
Di Filippo F, Giacomini P, Rossi CR, Santinami M, Garinei R, Anzà M, Deraco M, Botti C, Perri P, Cavaliere F, Di Angelo P, Sofra C, Sperduti I, Pasqualoni R, Di Filippo S, Corrias F, Armenti A, Ferraresi V. Di Filippo F, et al. Among authors: cavaliere f. In Vivo. 2009 Mar-Apr;23(2):363-7. In Vivo. 2009. PMID: 19414428 Free article. Clinical Trial.
Hyperthermic antiblastic perfusion for the treatment of soft tissue limb sarcoma.
Di Filippo F, Giannarelli D, Botti C, Carlini S, Cavaliere F, Garinei R, Schiratti M, Casaldi V, Tedesco M, Cavaliere R. Di Filippo F, et al. Among authors: cavaliere r, cavaliere f. Ann Oncol. 1992 Apr;3 Suppl 2:S71-4. doi: 10.1093/annonc/3.suppl_2.s71. Ann Oncol. 1992. PMID: 1622873 Free article. Clinical Trial.
Hyperthermic antiblastic perfusion with alpha tumor necrosis factor and doxorubicin for the treatment of soft tissue limb sarcoma in candidates for amputation: results of a phase I study.
Di Filippo F, Rossi CR, Vaglini M, Azzarelli A, Anzà M, Santinami M, Lise M, Cavaliere F, Giannarelli D, Quagliuolo V, Vecchiato A, Deraco M, Garinei R, Foletto M, Botti C, Cavaliere R. Di Filippo F, et al. Among authors: cavaliere r, cavaliere f. J Immunother. 1999 Sep;22(5):407-14. doi: 10.1097/00002371-199909000-00004. J Immunother. 1999. PMID: 10546156 Clinical Trial.
370 results